EBS Capital Expenditure

Emergent Biosolutions Inc · Capital Expenditure

EBS logo

EBS Capital Expenditure

Latest reported-$11.80M
EBS CapEx (-$225.00M → -$11.80M)
High-resolution chart · PNG

EBS capital expenditure history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Emergent Biosolutions Inc Capital Expenditure — Annual fiscal periods (USD)
Period endingCapital Expenditure (USD)
-13,800,000
-22,900,000
-51,600,000
-115,800,000
-225,000,000
-141,900,000
-86,900,000
-72,100,000
-54,828,000
-76,257,000
-44,812,000
-30,673,000
-42,021,000
-53,845,000
-54,026,000
-22,101,000
-33,287,000
-20,813,000
-43,969,000
-41,228,000
-6,532,000
-17,072,000
-225,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.